Our News on Newswise

Spiritual Themes, Distrust May Factor Into Black Patients’ Reluctance to Participate in Cancer Clinical Trials

Surveys from two Baltimore medical centers shed light on what may be fueling enrollment declines
26-Sep-2024 10:05 AM EDT Add to Favorites

Post-Mastectomy Radiation Therapy Can Be Shortened by Nearly Half for Patients Planning Breast Reconstruction

An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows. Findings of the large, phase III RT CHARM trial (Alliance A221505) will be...
26-Sep-2024 10:05 AM EDT Add to Favorites

Existing Standard Chemoradiation Superior to Deintensification Approaches for HPV-Related Oropharyngeal Cancer

Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III trial after patients in the control arm reached a...
26-Sep-2024 9:55 AM EDT Add to Favorites

Timing Matters When Adding Immunotherapy to Chemoradiation for Patients with Limited-Stage Small Cell Lung Cancer

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds.
26-Sep-2024 10:05 AM EDT Add to Favorites

IMRT and Proton Therapy Offer Equally High Quality of Life and Tumor Control for People with Prostate Cancer

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy — proton beam therapy or intensity modulated radiation therapy (IMRT) — achieved equally high rates of tumor control with...
26-Sep-2024 10:05 AM EDT Add to Favorites

People Who Experience Side Effects From Cranial Radiation Therapy May Recover Full Neurocognitive Function Within Months

Analysis of three large, phase III clinical trials finds more than 40% of brain metastases patients completely reversed cognitive losses
26-Sep-2024 10:05 AM EDT Add to Favorites

Radiopharmaceutical Therapy Offers Promise for People with Tough-to-Treat Meningioma Brain Tumors

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, a type of brain tumor....
26-Sep-2024 10:05 AM EDT Add to Favorites

Additional Research Highlights From the 2024 ASTRO Annual Meeting

In addition to the studies featured on the press program (details here) for the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting, the following studies were recommended by ASTRO experts and may be of interest to journalists.
26-Sep-2024 10:05 AM EDT Add to Favorites


See All News

Our YouTube Videos

About

The American Society for Radiation Oncology (ASTRO) is the largest radiation oncology society in the world, with roughly 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. Radiation therapy contributes to 40% of global cancer cures, and more than a million Americans receive radiation treatments for cancer each year. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics, Practical Radiation Oncology, and Advances in Radiation Oncology, and maintains an extensive patient information website, www.RTAnswers.org. To learn more about ASTRO, visit us at www.astro.org.

Experts

Twitter

Instagram

close
0.27457